{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:09:11Z","timestamp":1795100951033,"version":"4.10.3"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Migraine, a primary headache disorder whose mechanism remains incompletely understood, appears to involve the activation of the trigeminovascular system (TS) during attacks. Research suggests that inflammatory processes mediated by the immune system may play a role in migraine pathophysiology. Neuroinflammation is often associated with migraine attacks, with cytokines serving as crucial mediators in the process. Elevated levels of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1\u03b2), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-\u03b1), have been observed in the blood and cerebrospinal fluid of individuals experiencing migraine attacks. These cytokines have the capacity to sensitize pain pathways in the brain, thereby increasing sensitivity to pain stimuli. This phenomenon, known as central sensitization, is believed to contribute to the intensity and persistence of migraine pain. Kynurenines, endogenous mediators of glutamatergic mechanisms, can significantly influence the pathophysiology of primary headache disorders. The kynurenine system is collectively known as the kynurenine pathway (KP), which can act on multiple receptors, such as glutamate receptors, aryl hydrocarbon receptors (AhRs), G protein-coupled receptors 35 (GPR35), and \u03b1-7 nicotinic acetylcholine (\u03b17 nACh) receptors. These receptors are also found on various cells of the immune system, so the role of the KP in the pathomechanism of primary headaches may also be mediated through them. In this review, our goal is to show a possible link between the receptors of the KP and immune system in the context of inflammation and migraine. Migraine research in recent years has focused on neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as potential pathogenic factors and possible therapeutic approaches. These peptides share many similarities in their characteristics and roles. For instance, they exhibit potent vasodilation, occur in both the peripheral and central nervous systems, and play a role in transmitting nociception and neurogenic inflammation. The investigation of potential connections between the aforementioned neuropeptides and the kynurenine pathway could play a significant role in uncovering the pathomechanism of migraine and identifying new drug candidates.<\/jats:p>","DOI":"10.1186\/s10194-024-01833-z","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:02:34Z","timestamp":1722970954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The role of kynurenines in migraine-related neuroimmune pathways"],"prefix":"10.1186","volume":"25","author":[{"given":"Tam\u00e1s","family":"K\u00f6rt\u00e9si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Nagy-Gr\u00f3cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"1833_CR1","doi-asserted-by":"publisher","unstructured":"Ashina M, Migraine (2020) N Engl J Med. 383(19):1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327. PMID: 33211930","DOI":"10.1056\/NEJMra1915327"},{"key":"1833_CR2","doi-asserted-by":"publisher","unstructured":"Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol. 75:365\u2009\u2013\u200991. https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183717. Epub 2012 Nov 26. PMID: 23190076","DOI":"10.1146\/annurev-physiol-030212-183717"},{"issue":"4","key":"1833_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00702-010-0515-3","volume":"118","author":"J Tajti","year":"2011","unstructured":"Tajti J, P\u00e1rdutz A, V\u00e1mos E, Tuka B, Kuris A, Boh\u00e1r Z, Fejes A, Toldi J, V\u00e9csei L (2011) Migraine is a neuronal disease. J Neural Transm (Vienna) 118(4):511\u2013524. https:\/\/doi.org\/10.1007\/s00702-010-0515-3. Epub 2010 Dec 15. PMID: 21161301","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"1833_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0733-8619(18)30318-9","volume":"8","author":"MA Moskowitz","year":"1990","unstructured":"Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8(4):801\u2013815 PMID: 2175382","journal-title":"Neurol Clin"},{"key":"1833_CR5","doi-asserted-by":"publisher","unstructured":"Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol. 15(8):483\u2013490. https:\/\/doi.org\/10.1038\/s41582-019-0216-y. Epub 2019 Jul 1. PMID: 31263254","DOI":"10.1038\/s41582-019-0216-y"},{"issue":"9","key":"1833_CR6","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.3390\/ijms24098343","volume":"24","author":"G Yamanaka","year":"2023","unstructured":"Yamanaka G, Hayashi K, Morishita N, Takeshita M, Ishii C, Suzuki S, Ishimine R, Kasuga A, Nakazawa H, Takamatsu T, Watanabe Y, Morichi S, Ishida Y, Yamazaki T, Go S (2023) Experimental and clinical investigation of cytokines in Migraine: a narrative review. Int J Mol Sci 24(9):8343. https:\/\/doi.org\/10.3390\/ijms24098343. PMID: 37176049; PMCID: PMC10178908","journal-title":"Int J Mol Sci"},{"key":"1833_CR7","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Espada-Rubio S, Ag\u00fandez JAG (2024) Oxidative Stress and Migraine. Mol Neurobiol. Mar 18. https:\/\/doi.org\/10.1007\/s12035-024-04114-7. Epub ahead of print. PMID: 38499906","DOI":"10.1007\/s12035-024-04114-7"},{"key":"1833_CR8","doi-asserted-by":"publisher","first-page":"1377143","DOI":"10.1155\/2024\/1377143","volume":"2024","author":"A Sudershan","year":"2024","unstructured":"Sudershan A, Sudershan S, Sharma I, Kumar H, Panjaliya RK, Kumar P (2024) Role of TNF-\u03b1 in the pathogenesis of Migraine. Pain Res Manag 2024:1377143. https:\/\/doi.org\/10.1155\/2024\/1377143. PMID: 38213956; PMCID: PMC10781531","journal-title":"Pain Res Manag"},{"key":"1833_CR9","doi-asserted-by":"publisher","unstructured":"May A (2024 Jul-Aug) Beyond aura: understanding migraine as a cycling pan-sensory threshold disease. Headache 64(7):715\u2013717. https:\/\/doi.org\/10.1111\/head.14736. Epub 2024 May 23. PMID: 38779974","DOI":"10.1111\/head.14736"},{"issue":"1","key":"1833_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-024-01806-2","volume":"25","author":"E Noh","year":"2024","unstructured":"Noh E, Namgung JY, Park Y, Jang Y, Lee MJ, Park BY (2024) Shifts in structural connectome organization in the limbic and sensory systems of patients with episodic migraine. J Headache Pain 25(1):99. https:\/\/doi.org\/10.1186\/s10194-024-01806-2. PMID: 38862883; PMCID: PMC11165833","journal-title":"J Headache Pain"},{"key":"1833_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.npep.2015.03.006","volume":"52","author":"J Tajti","year":"2015","unstructured":"Tajti J, Szok D, Majl\u00e1th Z, Tuka B, Cs\u00e1ti A, V\u00e9csei L (2015) Migraine and neuropeptides. Neuropeptides 52:19\u201330. https:\/\/doi.org\/10.1016\/j.npep.2015.03.006. Epub 2015 Mar 30. Erratum in: Neuropeptides. 2016;60:91. PMID: 26094101","journal-title":"Neuropeptides"},{"issue":"1","key":"1833_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/ijms24010700","volume":"24","author":"E Spekker","year":"2022","unstructured":"Spekker E, K\u00f6rt\u00e9si T, V\u00e9csei LTRP, Channels (2022) Recent Development in Translational Research and potential therapeutic targets in Migraine. Int J Mol Sci 24(1):700. https:\/\/doi.org\/10.3390\/ijms24010700. PMID: 36614146; PMCID: PMC9820749","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1833_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s10194-019-0999-7","volume":"20","author":"T K\u00f6rt\u00e9si","year":"2019","unstructured":"K\u00f6rt\u00e9si T, Tuka B, Ny\u00e1ri A, V\u00e9csei L, Tajti J (2019) The effect of orofacial complete Freund\u2019s adjuvant treatment on the expression of migraine-related molecules. J Headache Pain 20(1):43. https:\/\/doi.org\/10.1186\/s10194-019-0999-7. PMID: 31035923; PMCID: PMC6734445","journal-title":"J Headache Pain"},{"issue":"2","key":"1833_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.peptides.2011.12.019","volume":"33","author":"B Tuka","year":"2012","unstructured":"Tuka B, Helyes Z, Markovics A, Bagoly T, N\u00e9meth J, M\u00e1rk L, Brubel R, Regl\u0151di D, P\u00e1rdutz A, Szolcs\u00e1nyi J, V\u00e9csei L, Tajti J (2012) Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system. Peptides 33(2):307\u2013316 Epub 2012 Jan 8. PMID: 22245521","journal-title":"Peptides"},{"issue":"1","key":"1833_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.nbd.2011.10.010","volume":"45","author":"A Markovics","year":"2012","unstructured":"Markovics A, Kormos V, Gaszner B, Lashgarara A, Szoke E, Sandor K, Szabadfi K, Tuka B, Tajti J, Szolcsanyi J, Pinter E, Hashimoto H, Kun J, Reglodi D, Helyes Z (2012) Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis 45(1):633\u2013644 Epub 2011 Oct 18. PMID: 22033344","journal-title":"Neurobiol Dis"},{"issue":"13","key":"1833_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","volume":"33","author":"B Tuka","year":"2013","unstructured":"Tuka B, Helyes Z, Markovics A, Bagoly T, Szolcs\u00e1nyi J, Szab\u00f3 N, T\u00f3th E, Kincses ZT, V\u00e9csei L, Tajti J (2013) Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia 33(13):1085\u20131095. https:\/\/doi.org\/10.1177\/0333102413483931. Epub 2013 Apr 18. PMID: 23598374","journal-title":"Cephalalgia"},{"issue":"19","key":"1833_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1212\/WNL.0000000000201332","volume":"99","author":"J Ailani","year":"2022","unstructured":"Ailani J, Kaiser EA, Mathew PG, McAllister P, Russo AF, V\u00e9lez C, Ramajo AP, Abdrabboh A, Xu C, Rasmussen S, Tepper SJ (2022) Role of calcitonin gene-related peptide on the gastrointestinal symptoms of migraine-clinical considerations: a narrative review. Neurology 99(19):841\u2013853. https:\/\/doi.org\/10.1212\/WNL.0000000000201332. PMID: 36127137; PMCID: PMC9651456","journal-title":"Neurology"},{"issue":"6","key":"1833_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/0333102420981666","volume":"41","author":"A Iljazi","year":"2021","unstructured":"Iljazi A, Ashina H, Zhuang ZA, Lopez Lopez C, Snellman J, Ashina M, Schytz HW (2021) Hypersensitivity to calcitonin gene-related peptide in chronic migraine. Cephalalgia 41(6):701\u2013710 Epub 2020 Dec 15. PMID: 33322922","journal-title":"Cephalalgia"},{"issue":"22","key":"1833_CR19","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/cells12222649","volume":"12","author":"M Tanaka","year":"2023","unstructured":"Tanaka M, Szab\u00f3 \u00c1, K\u00f6rt\u00e9si T, Szok D, Tajti J, V\u00e9csei L (2023) From CGRP to PACAP, VIP, and Beyond: unraveling the Next chapters in Migraine Treatment. Cells 12(22):2649. https:\/\/doi.org\/10.3390\/cells12222649. PMID: 37998384; PMCID: PMC10670698","journal-title":"Cells"},{"issue":"1","key":"1833_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s10194-022-01478-w","volume":"23","author":"T Acz\u00e9l","year":"2022","unstructured":"Acz\u00e9l T, Benczik B, \u00c1gg B, K\u00f6rt\u00e9si T, Urb\u00e1n P, Bauer W, Gyenesei A, Tuka B, Tajti J, Ferdinandy P, V\u00e9csei L, B\u00f6lcskei K, Kun J, Helyes Z (2022) Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress. J Headache Pain 23(1):113. https:\/\/doi.org\/10.1186\/s10194-022-01478-w. PMID: 36050647; PMCID: PMC9438144","journal-title":"J Headache Pain"},{"key":"1833_CR21","unstructured":"Bruno PP, Carpino F, Carpino G, Zicari A (2007) Jul-Aug;11(4):245-8 An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. PMID: 17876959"},{"key":"1833_CR22","doi-asserted-by":"publisher","first-page":"874193","DOI":"10.3389\/fneur.2022.874193","volume":"13","author":"LK Balcziak","year":"2022","unstructured":"Balcziak LK, Russo AF (2022) Dural Immune Cells, CGRP, and Migraine. Front Neurol 13:874193. https:\/\/doi.org\/10.3389\/fneur.2022.874193. PMID: 35432179; PMCID: PMC9009415","journal-title":"Front Neurol"},{"key":"1833_CR23","doi-asserted-by":"publisher","unstructured":"Kemper RH, Meijler WJ, Korf J, Ter Horst GJ (2001) Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia. 21(5):549\u2009\u2013\u200957. https:\/\/doi.org\/10.1046\/j.1468-2982.2001.00196.x. PMID: 11472381","DOI":"10.1046\/j.1468-2982.2001.00196.x"},{"issue":"Pt 5","key":"1833_CR24","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A et al (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115(Pt 5):1249\u20131273. https:\/\/doi.org\/10.1093\/brain\/115.5.1249","journal-title":"Brain"},{"issue":"11","key":"1833_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N M\u00fcller","year":"2007","unstructured":"M\u00fcller N, Schwarz MJ (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12(11):988\u20131000. https:\/\/doi.org\/10.1038\/sj.mp.4002006","journal-title":"Mol Psychiatry"},{"issue":"20","key":"1833_CR26","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.3390\/molecules24203709","volume":"24","author":"F Z\u00e1dor","year":"2019","unstructured":"Z\u00e1dor F, Nagy-Gr\u00f3cz G, Kekesi G, Dvor\u00e1csk\u00f3 S, Sz\u0171cs E, T\u00f6mb\u00f6ly C, Horvath G, Benyhe S (2019) V\u00e9csei., L. Kynurenines and the Endocannabinoid System in Schizophrenia: common points and potential interactions. Molecules 24(20):3709. https:\/\/doi.org\/10.3390\/molecules24203709","journal-title":"Molecules"},{"issue":"8","key":"1833_CR27","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/ijms18081617","volume":"18","author":"G Nagy-Gr\u00f3cz","year":"2017","unstructured":"Nagy-Gr\u00f3cz G, Z\u00e1dor F, Dvor\u00e1csk\u00f3 S, Boh\u00e1r Z, Benyhe S, T\u00f6mb\u00f6ly C, P\u00e1rdutz \u00c1, V\u00e9csei L (2017) Interactions between the Kynurenine and the Endocannabinoid System with special emphasis on Migraine. Int J Mol Sci 18(8):1617. https:\/\/doi.org\/10.3390\/ijms18081617","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1833_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.2174\/0929867324666170227115019","volume":"24","author":"J Tajti","year":"2017","unstructured":"Tajti J, Szok D, Nagy-Grocz G, Tuka B, Petrovics-Balog A, Toldi J, Vecsei L (2017) Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic aspects. Curr Med Chem 24(13):1332\u20131349. https:\/\/doi.org\/10.2174\/0929867324666170227115019","journal-title":"Curr Med Chem"},{"issue":"1","key":"1833_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-2999(88)90367-6","volume":"154","author":"PJ Birch","year":"1988","unstructured":"Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenic acid antagonises responses to NMDA via an action at the strych-nine-insensitive glycine receptor. Eur J Pharmacol 154(1):85\u201328. https:\/\/doi.org\/10.1016\/0014-2999(88)90367-6","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1833_CR30","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","volume":"52","author":"M Kessler","year":"1989","unstructured":"Kessler M, Terramani T, Lynch G, Baudry MA (1989) Glycine site Associated with N-Methyl\u2010d\u2010Aspartic acid receptors: Char-acterization and identification of a New Class of antagonists. J Neurochem 52(4):1319\u20131328. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb01881.x","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1833_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neulet.2006.03.051","volume":"402","author":"C Prescott","year":"2006","unstructured":"Prescott C, Weeks AM, Staley KJ, Partin KM (2006) Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402(1\u20132):108\u2013112. https:\/\/doi.org\/10.1016\/j.neulet.2006.03.051","journal-title":"Neurosci Lett"},{"issue":"8","key":"1833_CR32","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00702-008-0052-5","volume":"115","author":"E R\u00f3zsa","year":"2008","unstructured":"R\u00f3zsa E, Robotka H, V\u00e9csei L, Toldi J (2008) The Janus-face kynurenic acid. J Neural Transm (Vienna) 115(8):1087\u20131091. https:\/\/doi.org\/10.1007\/s00702-008-0052-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"1833_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","volume":"121","author":"Y Ganor","year":"2014","unstructured":"Ganor Y, Levite M (2014) The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm (Vienna) 121(8):983\u20131006. https:\/\/doi.org\/10.1007\/s00702-014-1167-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"1833_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1523\/JNEUROSCI.20-01-00251.2000","volume":"20","author":"M Noda","year":"2000","unstructured":"Noda M, Nakanishi H, Nabekura J, Akaike N (2000) AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20(1):251\u2013258. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-01-00251.2000","journal-title":"J Neurosci"},{"issue":"5","key":"1833_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/glia.20783","volume":"57","author":"KR Byrnes","year":"2009","unstructured":"Byrnes KR, Stoica B, Loane DJ, Riccio A, Davis MI, Faden AI (2009) Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 57(5):550\u2013560. https:\/\/doi.org\/10.1002\/glia.20783","journal-title":"Glia"},{"issue":"10","key":"1833_CR36","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.4049\/jimmunol.177.10.6695","volume":"177","author":"R Pacheco","year":"2006","unstructured":"Pacheco R, Oliva H, Martinez-Nav\u00edo JM, Climent N, Ciruela F, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R (2006) Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol 177(10):6695\u20136704. https:\/\/doi.org\/10.4049\/jimmunol.177.10.6695","journal-title":"J Immunol"},{"issue":"4","key":"1833_CR37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ana.23626","volume":"72","author":"AM Kaindl","year":"2012","unstructured":"Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, Le Charpentier T, Josserand J, Ali C, Vivien D, Collingridge GL, Lombet A, Issa L, Rene F, Loeffler JP, Kavelaars A, Verney C, Mantz J, Gressens P (2012) Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 72(4):536\u2013549. https:\/\/doi.org\/10.1002\/ana.23626","journal-title":"Ann Neurol"},{"issue":"1","key":"1833_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87(1):10\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.10.004","journal-title":"Brain Res Bull"},{"issue":"2","key":"1833_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells8020184","volume":"8","author":"S Mahmoud","year":"2019","unstructured":"Mahmoud S, Gharagozloo M, Simard C, Gris D (2019) Astrocytes maintain glutamate homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release. Cells 8(2):184. https:\/\/doi.org\/10.3390\/cells8020184","journal-title":"Cells"},{"issue":"12","key":"1833_CR40","doi-asserted-by":"publisher","first-page":"9903","DOI":"10.3390\/ijms24129903","volume":"24","author":"M G\u0105ssowska-Dobrowolska","year":"2023","unstructured":"G\u0105ssowska-Dobrowolska M, Chlubek M, Kolasa A, Tomasiak P, Korbecki J, Skowro\u0144ska K, Tarnowski M, Masztalewicz M, Baranowska-Bosiacka I (2023) Microglia and astroglia-the potential role in Neuroinflammation Induced by pre- and neonatal exposure to lead (pb). Int J Mol Sci 24(12):9903. https:\/\/doi.org\/10.3390\/ijms24129903","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1833_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.156","volume":"375","author":"CF Vogel","year":"2008","unstructured":"Vogel CF, Goth SR, Dong B, Pessah IN, Matsumura F (2008) Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 375(3):331\u2013335. https:\/\/doi.org\/10.1016\/j.bbrc.2008.07.156","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1833_CR42","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1074\/jbc.M113.505578","volume":"289","author":"CF Vogel","year":"2014","unstructured":"Vogel CF, Khan EM, Leung PS, Gershwin ME, Chang WL, Wu D, Haarmann-Stemmann T, Hoffmann A, Denison MS (2014) Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-\u03baB. J Biol Chem 289(3):1866\u20131875. https:\/\/doi.org\/10.1074\/jbc.M113.505578","journal-title":"J Biol Chem"},{"key":"1833_CR43","doi-asserted-by":"publisher","first-page":"110797","DOI":"10.1016\/j.exger.2019.110797","volume":"130","author":"H Kaiser","year":"2020","unstructured":"Kaiser H, Parker E, Hamrick MW (2020) Kynurenine signaling through the aryl hydrocarbon receptor: implications for aging and healthspan. Exp Gerontol 130:110797. https:\/\/doi.org\/10.1016\/j.exger.2019.110797","journal-title":"Exp Gerontol"},{"issue":"1\u20132","key":"1833_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-016-2862-3","volume":"425","author":"D Brauze","year":"2017","unstructured":"Brauze D, Zawierucha P, Kiwerska K, Bednarek K, Oleszak M, Rydzanicz M, Jarmuz-Szymczak M (2017) Induction of expression of aryl hydrocarbon receptor-dependent genes in human HepaRG cell line modified by shRNA and treated with \u03b2-naphthoflavone. Mol Cell Biochem 425(1\u20132):59\u201375. https:\/\/doi.org\/10.1007\/s11010-016-2862-3","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"1833_CR45","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1084\/jem.20090560","volume":"206","author":"A Kimura","year":"2009","unstructured":"Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, Nohara K, Fujii-Kuriyama Y, Kishimoto T (2009) Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206(9):2027\u20132035. https:\/\/doi.org\/10.1084\/jem.20090560","journal-title":"J Exp Med"},{"issue":"7508","key":"1833_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature13323","volume":"511","author":"A Bessede","year":"2014","unstructured":"Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P (2014) Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511(7508):184\u2013190. https:\/\/doi.org\/10.1038\/nature13323","journal-title":"Nature"},{"issue":"6","key":"1833_CR47","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185(6):3190\u20133198. https:\/\/doi.org\/10.4049\/jimmunol.0903670. Epub 2010 Aug 18","journal-title":"J Immunol"},{"key":"1833_CR48","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/npjbiofilms.2016.14","volume":"2","author":"A Korecka","year":"2016","unstructured":"Korecka A, Dona A, Lahiri S, Tett AJ, Al-Asmakh M, Braniste V, D\u2019Arienzo R, Abbaspour A, Reichardt N, Fujii-Kuriyama Y, Rafter J, Narbad A, Holmes E, Nicholson J, Arulampalam V, Pettersson S (2016) Bidirectional communication between the Aryl hydrocarbon receptor (AhR) and the microbiome tunes host metabolism. NPJ Biofilms Microbiomes 2:16014. https:\/\/doi.org\/10.1038\/npjbiofilms.2016.14","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"2","key":"1833_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/nu15020305","volume":"15","author":"FC Huang","year":"2023","unstructured":"Huang FC, Huang SC (2023) The pivotal role of Aryl Hydrocarbon Receptor-Regulated Tight Junction Proteins and Innate Immunity on the synergistic effects of Postbiotic Butyrate and active vitamin D3 to defense against Microbial Invasion in Salmonella Colitis. Nutrients 15(2):305. https:\/\/doi.org\/10.3390\/nu15020305","journal-title":"Nutrients"},{"issue":"1","key":"1833_CR50","doi-asserted-by":"publisher","first-page":"111963","DOI":"10.1016\/j.celrep.2022.111963","volume":"42","author":"JW Dean","year":"2023","unstructured":"Dean JW, Helm EY, Fu Z, Xiong L, Sun N, Oliff KN, Muehlbauer M, Avram D, Zhou L (2023) The aryl hydrocarbon receptor cell intrinsically promotes resident memory CD8\u2009+\u2009T cell differentiation and function. Cell Rep 42(1):111963. https:\/\/doi.org\/10.1016\/j.celrep.2022.111963","journal-title":"Cell Rep"},{"issue":"640","key":"1833_CR51","doi-asserted-by":"publisher","first-page":"eabl6157","DOI":"10.1126\/scitranslmed.abl6157","volume":"14","author":"D Frieser","year":"2022","unstructured":"Frieser D, Pignata A, Khajavi L, Shlesinger D, Gonzalez-Fierro C, Nguyen XH, Yermanos A, Merkler D, H\u00f6ftberger R, Desestret V, Mair KM, Bauer J, Masson F, Liblau RS (2022) Tissue-resident CD8\u2009+\u2009T cells drive compartmentalized and chronic autoimmune damage against CNS neurons. Sci Transl Med 14(640):eabl6157. https:\/\/doi.org\/10.1126\/scitranslmed.abl6157","journal-title":"Sci Transl Med"},{"issue":"11","key":"1833_CR52","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1007\/s10620-018-5216-z","volume":"63","author":"SM Farooq","year":"2018","unstructured":"Farooq SM, Hou Y, Li H, O\u2019Meara M, Wang Y, Li C, Wang JM (2018) Disruption of GPR35 exacerbates Dextran Sulfate Sodium-Induced Colitis in mice. Dig Dis Sci 63(11):2910\u20132922. https:\/\/doi.org\/10.1007\/s10620-018-5216-z","journal-title":"Dig Dis Sci"},{"key":"1833_CR53","doi-asserted-by":"publisher","unstructured":"De Giovanni M, Tam H, Valet C, Xu Y, Looney MR, Cyster JG (2022) GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA. Cell. 185(5):815\u2013830.e19. https:\/\/doi.org\/10.1016\/j.cell.2022.01.010. Epub 2022 Feb 10. Erratum in: Cell. 2022;185(6):1103\u20131104","DOI":"10.1016\/j.cell.2022.01.010"},{"key":"1833_CR54","doi-asserted-by":"publisher","first-page":"1254446","DOI":"10.3389\/fimmu.2023.1254446","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhang P, Fan H, Zhang C, Yu P, Liang X, Chen Y (2023) GPR35 acts a dual role and therapeutic target in inflammation. Front Immunol 14:1254446. https:\/\/doi.org\/10.3389\/fimmu.2023.1254446","journal-title":"Front Immunol"},{"issue":"31","key":"1833_CR55","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281(31):22021\u201322028. https:\/\/doi.org\/10.1074\/jbc.M603503200","journal-title":"J Biol Chem"},{"issue":"6","key":"1833_CR56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/jnc.14907","volume":"152","author":"TW Stone","year":"2020","unstructured":"Stone TW (2020) Does kynurenic acid act on nicotinic receptors? An assessment of the evidence. J Neurochem 152(6):627\u2013649. https:\/\/doi.org\/10.1111\/jnc.14907","journal-title":"J Neurochem"},{"issue":"1","key":"1833_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2017.05.002","volume":"134","author":"T Fujii","year":"2017","unstructured":"Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K, Kawashima K (2017) Physiological functions of the cholinergic system in immune cells. J Pharmacol Sci 134(1):1\u201321. https:\/\/doi.org\/10.1016\/j.jphs.2017.05.002","journal-title":"J Pharmacol Sci"},{"key":"1833_CR58","doi-asserted-by":"publisher","first-page":"106276","DOI":"10.1016\/j.intimp.2020.106276","volume":"81","author":"M Mashimo","year":"2020","unstructured":"Mashimo M, Takeshima S, Okuyama H, Matsurida A, Murase M, Ono S, Kawashima K, Fujii T (2020) \u03b17 nAChRs expressed on antigen presenting cells are insensitive to the conventional antagonists \u03b1-bungarotoxin and methyllycaconitine. Int Immunopharmacol 81:106276. https:\/\/doi.org\/10.1016\/j.intimp.2020.106276","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1833_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2008.06.018","volume":"203","author":"E Nizri","year":"2008","unstructured":"Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, Brenner T (2008) Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 203(1):12\u201322. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.018","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1833_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0304-3940(99)00259-1","volume":"266","author":"KZ Sato","year":"1999","unstructured":"Sato KZ, Fujii T, Watanabe Y, Yamada S, Ando T, Kazuko F, Kawashima K (1999) Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266(1):17\u201320. https:\/\/doi.org\/10.1016\/s0304-3940(99)00259-1","journal-title":"Neurosci Lett"},{"issue":"32","key":"1833_CR61","doi-asserted-by":"publisher","first-page":"16541","DOI":"10.1074\/jbc.M115.710574","volume":"291","author":"SR Zanetti","year":"2016","unstructured":"Zanetti SR, Ziblat A, Torres NI, Zwirner NW, Bouzat C (2016) Expression and functional role of \u03b17 nicotinic receptor in human cytokine-stimulated natural killer (NK) cells. J Biol Chem 291(32):16541\u201316552. https:\/\/doi.org\/10.1074\/jbc.M115.710574","journal-title":"J Biol Chem"},{"issue":"2","key":"1833_CR62","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1471-4159.2004.02347.x","volume":"89","author":"RD Shytle","year":"2004","unstructured":"Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, Tan J (2004) Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89(2):337\u2013343. https:\/\/doi.org\/10.1046\/j.1471-4159.2004.02347.x","journal-title":"J Neurochem"},{"issue":"1","key":"1833_CR63","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-017-0967-6","volume":"14","author":"H Patel","year":"2017","unstructured":"Patel H, McIntire J, Ryan S, Dunah A, Loring R (2017) Anti-inflammatory effects of astroglial \u03b17 nicotinic acetylcholine receptors are mediated by inhibition of the NF-\u03baB pathway and activation of the Nrf2 pathway. J Neuroinflammation 14(1):192. https:\/\/doi.org\/10.1186\/s12974-017-0967-6","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"1833_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jneuroim.2012.07.006","volume":"251","author":"MS Thomsen","year":"2012","unstructured":"Thomsen MS, Mikkelsen JD (2012) The \u03b17 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-\u03b1 release from microglia. J Neuroimmunol 251(1\u20132):65\u201372. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.07.006","journal-title":"J Neuroimmunol"},{"key":"1833_CR65","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fncel.2017.00189","volume":"11","author":"A Zakrzewicz","year":"2017","unstructured":"Zakrzewicz A, Richter K, Agn\u00e9 A, Wilker S, Siebers K, Fink B, Krasteva-Christ G, Althaus M, Padberg W, Hone AJ, McIntosh JM, Grau V (2017) Canonical and Novel Non-canonical Cholinergic agonists Inhibit ATP-Induced release of monocytic Interleukin-1\u03b2 via different combinations of nicotinic acetylcholine receptor subunits \u03b17, \u03b19 and \u03b110. Front Cell Neurosci 11:189. https:\/\/doi.org\/10.3389\/fncel.2017.00189","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1833_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12974-021-02149-4","volume":"18","author":"T Mizrachi","year":"2021","unstructured":"Mizrachi T, Marsha O, Brusin K, Ben-David Y, Thakur GA, Vaknin-Dembinsky A, Treinin M, Brenner T (2021) Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor GAT107. J Neuroinflammation 18(1):99. https:\/\/doi.org\/10.1186\/s12974-021-02149-4","journal-title":"J Neuroinflammation"},{"issue":"10","key":"1833_CR67","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.4049\/jimmunol.0902212","volume":"183","author":"E Nizri","year":"2009","unstructured":"Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T (2009) Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 183(10):6681\u20136688. https:\/\/doi.org\/10.4049\/jimmunol.0902212","journal-title":"J Immunol"},{"issue":"12","key":"1833_CR68","doi-asserted-by":"publisher","first-page":"e0256507","DOI":"10.1371\/journal.pone.0256507","volume":"16","author":"X Zhu","year":"2021","unstructured":"Zhu X, Dai S, Xia B, Gong J, Ma B (2021) Activation of the alpha 7 nicotinic acetylcholine receptor mitigates osteoarthritis progression by inhibiting NF-\u03baB\/NLRP3 inflammasome activation and enhancing autophagy. PLoS ONE 16(12):e0256507. https:\/\/doi.org\/10.1371\/journal.pone.0256507","journal-title":"PLoS ONE"},{"issue":"21","key":"1833_CR69","doi-asserted-by":"publisher","first-page":"15732","DOI":"10.3390\/ijms242115732","volume":"24","author":"N Roa-Vidal","year":"2023","unstructured":"Roa-Vidal N, Rodr\u00edguez-Aponte AS, Lasalde-Dominicci JA, Cap\u00f3-V\u00e9lez CM (2023) Delgado-V\u00e9lez, M. Cholinergic polarization of human macrophages. Int J Mol Sci 24(21):15732. https:\/\/doi.org\/10.3390\/ijms242115732","journal-title":"Int J Mol Sci"},{"key":"1833_CR70","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2741\/1390","volume":"9","author":"K Kawashima","year":"2004","unstructured":"Kawashima K, Fujii T (2004) Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 9:2063\u20132085. https:\/\/doi.org\/10.2741\/1390","journal-title":"Front Biosci"},{"issue":"2","key":"1833_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.imlet.2007.02.005","volume":"109","author":"M Nouri-Shirazi","year":"2007","unstructured":"Nouri-Shirazi M, Tinajero R, Guinet E (2007) Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs). Immunol Lett 109(2):155\u2013164. https:\/\/doi.org\/10.1016\/j.imlet.2007.02.005","journal-title":"Immunol Lett"},{"issue":"4","key":"1833_CR72","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.4049\/jimmunol.175.4.2684","volume":"175","author":"R Vassallo","year":"2005","unstructured":"Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L (2005) Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 175(4):2684\u20132691. https:\/\/doi.org\/10.4049\/jimmunol.175.4.2684","journal-title":"J Immunol"},{"issue":"1","key":"1833_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2014.01.029","volume":"89","author":"RL Papke","year":"2014","unstructured":"Papke RL (2014) Merging old and new perspectives on nicotinic acetylcholine receptors. Biochem Pharmacol 89(1):1\u201311. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.029. Epub 2014 Jan 31. PMID: 24486571; PMCID: PMC4755309","journal-title":"Biochem Pharmacol"},{"key":"1833_CR74","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","volume":"47","author":"JA Dani","year":"2007","unstructured":"Dani JA, Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699\u2013729. https:\/\/doi.org\/10.1146\/annurev.pharmtox.47.120505.105214","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6921","key":"1833_CR75","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421(6921):384\u2013388. https:\/\/doi.org\/10.1038\/nature01339","journal-title":"Nature"},{"issue":"20","key":"1833_CR76","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.3390\/molecules26206097","volume":"26","author":"MI Hollenhorst","year":"2021","unstructured":"Hollenhorst MI, Krasteva-Christ G (2021) Nicotinic acetylcholine receptors in the respiratory tract. Molecules 26(20):6097. https:\/\/doi.org\/10.3390\/molecules26206097","journal-title":"Molecules"},{"key":"1833_CR77","doi-asserted-by":"publisher","first-page":"e933978","DOI":"10.12659\/MSM.933978","volume":"28","author":"K Cao","year":"2022","unstructured":"Cao K, Xiang J, Dong YT, Xu Y, Guan ZZ (2022) Activation of \u03b17 nicotinic acetylcholine receptor by its selective agonist improved learning and Memory of Amyloid Precursor Protein\/Presenilin 1 (APP\/PS1) mice via the Nrf2\/HO-1 pathway. Med Sci Monit 28:e933978. https:\/\/doi.org\/10.12659\/MSM.933978","journal-title":"Med Sci Monit"},{"issue":"23","key":"1833_CR78","doi-asserted-by":"publisher","first-page":"16574","DOI":"10.3390\/ijms242316574","volume":"24","author":"E Spekker","year":"2023","unstructured":"Spekker E, Nagy-Gr\u00f3cz G, V\u00e9csei L (2023) Ion Channel disturbances in Migraine Headache: exploring the potential role of the Kynurenine System in the context of the Trigeminovascular System. Int J Mol Sci 24(23):16574. https:\/\/doi.org\/10.3390\/ijms242316574","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1833_CR79","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-2982.2009.01983.x","volume":"29","author":"A Charles","year":"2009","unstructured":"Charles A, Brennan K (2009) Cortical spreading depression-new insights and persistent questions. Cephalalgia 29(10):1115\u20131124. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01983.x","journal-title":"Cephalalgia"},{"issue":"4","key":"1833_CR80","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/187152707781387279","volume":"6","author":"M Vikelis","year":"2007","unstructured":"Vikelis M, Mitsikostas DD (2007) The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 6(4):251\u2013257. https:\/\/doi.org\/10.2174\/187152707781387279","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"1833_CR81","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/head.14599","volume":"63","author":"L Yang","year":"2023","unstructured":"Yang L, Zhou Y, Zhang L, Wang Y, Zhang Y, Xiao Z (2023) Aryl hydrocarbon receptors improve migraine-like pain behaviors in rats through the regulation of regulatory T cell\/T-helper 17 cell-related homeostasis. Headache 63(8):1045\u20131060. https:\/\/doi.org\/10.1111\/head.14599","journal-title":"Headache"},{"issue":"7\u20138","key":"1833_CR82","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neuropharm.2010.11.014","volume":"60","author":"C Cosi","year":"2011","unstructured":"Cosi C, Mannaioni G, Cozzi A, Carl\u00e0 V, Sili M, Cavone L, Maratea D, Moroni F (2011) G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast. Neuropharmacology 60(7\u20138):1227\u20131231. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.11.014","journal-title":"Neuropharmacology"},{"issue":"4","key":"1833_CR83","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1124\/mol.110.066746","volume":"78","author":"P Zhao","year":"2010","unstructured":"Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, Adler MW, Seltzman HH, Reggio PH, Heynen-Genel S, Sauer M, Chung TD, Bai Y, Chen W, Caron MG, Barak LS, Abood ME (2010) Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and \u03b2-arrestin2 with antinociceptive activity. Mol Pharmacol 78(4):560\u2013568. https:\/\/doi.org\/10.1124\/mol.110.066746","journal-title":"Mol Pharmacol"},{"key":"1833_CR84","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/JPR.S159146","volume":"11","author":"Q Liu","year":"2018","unstructured":"Liu Q, Liu C, Jiang L, Li M, Long T, He W, Qin G, Chen L, Zhou J (2018) \u03b17 nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation. J Pain Res 11:1129\u20131140. https:\/\/doi.org\/10.2147\/JPR.S159146","journal-title":"J Pain Res"},{"issue":"2","key":"1833_CR85","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0006-8993(98)00862-2","volume":"809","author":"L Liu","year":"1998","unstructured":"Liu L, Chang GQ, Jiao YQ, Simon SA (1998) Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res 809(2):238\u2013245. https:\/\/doi.org\/10.1016\/s0006-8993(98)00862-2","journal-title":"Brain Res"},{"issue":"5","key":"1833_CR86","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the Trigeminal System in Migraine. Headache 59(5):659\u2013681. https:\/\/doi.org\/10.1111\/head.13529","journal-title":"Headache"},{"key":"1833_CR87","doi-asserted-by":"publisher","first-page":"727593","DOI":"10.3389\/fmed.2021.727593","volume":"8","author":"R Mehboob","year":"2021","unstructured":"Mehboob R, Kurdi M, Bamaga A, Aldardeir N, Nasief H, Moshref LH, Alsinani T, Rayes AO, Jabbad RH, Substance P (2021) Neurokinin-1 receptor, trigeminal ganglion, latency, and coronavirus Infection-Is there any link? Front Med (Lausanne) 8:727593. https:\/\/doi.org\/10.3389\/fmed.2021.727593","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1833_CR88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cei\/uxab025","volume":"207","author":"L Biscetti","year":"2022","unstructured":"Biscetti L, De Vanna G, Cresta E, Bellotti A, Corbelli I, Letizia Cupini M, Calabresi P, Sarchielli P (2022) Immunological findings in patients with migraine and other primary headaches: a narrative review. Clin Exp Immunol 207(1):11\u201326. https:\/\/doi.org\/10.1093\/cei\/uxab025","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1833_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10194-021-01271-1","volume":"22","author":"O Kursun","year":"2021","unstructured":"Kursun O, Yemisci M, van den Maagdenberg AMJM, Karatas H (2021) Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain 22(1):55. https:\/\/doi.org\/10.1186\/s10194-021-01271-1","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1673-5374.198971","volume":"12","author":"N Braidy","year":"2017","unstructured":"Braidy N, Grant R (2017) Kynurenine pathway metabolism and neuroinflammatory disease. Neural Regen Res 12(1):39\u201342. https:\/\/doi.org\/10.4103\/1673-5374.198971","journal-title":"Neural Regen Res"},{"key":"1833_CR91","doi-asserted-by":"publisher","first-page":"716859","DOI":"10.4061\/2011\/716859","volume":"2011","author":"A Zinger","year":"2011","unstructured":"Zinger A, Barcia C, Herrero MT, Guillemin GJ (2011) The involvement of neuroinflammation and kynurenine pathway in Parkinson\u2019s disease. Parkinsons Dis 2011:716859. https:\/\/doi.org\/10.4061\/2011\/716859","journal-title":"Parkinsons Dis"},{"key":"1833_CR92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/brainsci14040317","volume":"14","author":"E Spekker","year":"2024","unstructured":"Spekker E, Fejes-Szab\u00f3 A, Nagy-Gr\u00f3cz G (2024) Models of trigeminal activation: is there an animal model of Migraine? Brain Sci 14:317. https:\/\/doi.org\/10.3390\/brainsci14040317","journal-title":"Brain Sci"},{"issue":"9","key":"1833_CR93","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1177\/0333102415613766","volume":"36","author":"G Nagy-Gr\u00f3cz","year":"2016","unstructured":"Nagy-Gr\u00f3cz G, Tar L, Boh\u00e1r Z, Fejes-Szab\u00f3 A, Laborc KF, Spekker E, V\u00e9csei L, P\u00e1rdutz \u00c1 (2016) The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat. Cephalalgia 36(9):849\u2013861. https:\/\/doi.org\/10.1177\/0333102415613766","journal-title":"Cephalalgia"},{"key":"1833_CR94","doi-asserted-by":"crossref","unstructured":"Nagy-Gr\u00f3cz G, Laborc KF, Veres G, Bajtai A, Boh\u00e1r Z, Z\u00e1dori D, Fejes-Szab\u00f3 A, Spekker E, V\u00e9csei L, P\u00e1rdutz \u00c1 (2017) The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat. Front Neurol. 8:278. doi: 10.3389\/fneur.2017.00278. Erratum in: Front Neurol. 2020;11:1049","DOI":"10.3389\/fneur.2017.00278"},{"issue":"1","key":"1833_CR95","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s10194-020-01169-4","volume":"21","author":"KF Laborc","year":"2020","unstructured":"Laborc KF, Spekker E, Boh\u00e1r Z, Sz\u0171cs M, Nagy-Gr\u00f3cz G, Fejes-Szab\u00f3 A, V\u00e9csei L, P\u00e1rdutz \u00c1 (2020) Trigeminal activation patterns evoked by chemical stimulation of the dura mater in rats. J Headache Pain 21(1):101. https:\/\/doi.org\/10.1186\/s10194-020-01169-4","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-021-01229-3","volume":"22","author":"E Spekker","year":"2021","unstructured":"Spekker E, Laborc KF, Boh\u00e1r Z, Nagy-Gr\u00f3cz G, Fejes-Szab\u00f3 A, Sz\u0171cs M, V\u00e9csei L, P\u00e1rdutz \u00c1 (2021) Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid. J Headache Pain 22(1):17. https:\/\/doi.org\/10.1186\/s10194-021-01229-3","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR97","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s10194-019-0999-7","volume":"20","author":"T K\u00f6rt\u00e9si","year":"2019","unstructured":"K\u00f6rt\u00e9si T, Tuka B, Ny\u00e1ri A, V\u00e9csei L, Tajti J (2019) The effect of orofacial complete Freund\u2019s adjuvant treatment on the expression of migraine-related molecules. J Headache Pain 20(1):43. https:\/\/doi.org\/10.1186\/s10194-019-0999-7","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-020-01105-6","volume":"21","author":"EK Cseh","year":"2020","unstructured":"Cseh EK, Veres G, K\u00f6rt\u00e9si T, Poly\u00e1k H, N\u00e1n\u00e1si N, Tajti J, P\u00e1rdutz \u00c1, Kliv\u00e9nyi P, V\u00e9csei L, Z\u00e1dori D (2020) Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund\u2019s adjuvant model of orofacial pain. J Headache Pain 21(1):35. https:\/\/doi.org\/10.1186\/s10194-020-01105-6","journal-title":"J Headache Pain"},{"key":"1833_CR99","doi-asserted-by":"publisher","unstructured":"Oshinsky ML, Gomonchareonsiri S (2007 Jul-Aug) Episodic dural stimulation in awake rats: a model for recurrent headache. Headache 47(7):1026\u20131036. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00871.x","DOI":"10.1111\/j.1526-4610.2007.00871.x"},{"key":"1833_CR100","doi-asserted-by":"publisher","first-page":"1082176","DOI":"10.3389\/fneur.2023.1082176","volume":"14","author":"PV Reducha","year":"2023","unstructured":"Reducha PV, B\u00f6mers JP, Edvinsson L, Haanes KA (2023) Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment. Front Neurol 14:1082176. https:\/\/doi.org\/10.3389\/fneur.2023.1082176","journal-title":"Front Neurol"},{"issue":"2","key":"1833_CR101","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","volume":"28","author":"P Raboisson","year":"2004","unstructured":"Raboisson P, Dallel R (2004) The orofacial formalin test. Neurosci Biobehav Rev 28(2):219\u2013226. https:\/\/doi.org\/10.1016\/j.neubiorev.2003.12.003","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1833_CR102","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00702-016-1615-5","volume":"124","author":"G Veres","year":"2017","unstructured":"Veres G, Fejes-Szab\u00f3 A, Z\u00e1dori D, Nagy-Gr\u00f3cz G, L\u00e1szl\u00f3 AM, Bajtai A, M\u00e1ndity I, Szentirmai M, Boh\u00e1r Z, Laborc K, Szatm\u00e1ri I, F\u00fcl\u00f6p F, V\u00e9csei L, P\u00e1rdutz \u00c1 (2017) A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study. J Neural Transm (Vienna) 124(1):99\u2013112. https:\/\/doi.org\/10.1007\/s00702-016-1615-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"1833_CR103","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2174\/1871527314666150225141229","volume":"14","author":"A Fejes-Szab\u00f3","year":"2015","unstructured":"Fejes-Szab\u00f3 A, Boh\u00e1r Z, Nagy-Gr\u00f3cz G, V\u00e1mos E, Tar L, P\u0151d\u00f6r B, Tajti J, Toldi J, V\u00e9csei L, P\u00e1rdutz \u00c1 (2015) Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat. CNS Neurol Disord Drug Targets 14(3):350\u2013359. https:\/\/doi.org\/10.2174\/1871527314666150225141229","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"1833_CR104","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/cells10071603","volume":"10","author":"A Mor","year":"2021","unstructured":"Mor A, Tankiewicz-Kwedlo A, Krupa A, Pawlak D (2021) Role of Kynurenine Pathway in oxidative stress during neurodegenerative disorders. Cells 10(7):1603. https:\/\/doi.org\/10.3390\/cells10071603","journal-title":"Cells"},{"issue":"3","key":"1833_CR105","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/ijms25031698","volume":"25","author":"G Nagy-Gr\u00f3cz","year":"2024","unstructured":"Nagy-Gr\u00f3cz G, Spekker E, V\u00e9csei L, Kynurenines (2024) Neuronal excitotoxicity, and mitochondrial oxidative stress: role of the Intestinal Flora. Int J Mol Sci 25(3):1698. https:\/\/doi.org\/10.3390\/ijms25031698","journal-title":"Int J Mol Sci"},{"key":"1833_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10194-016-0638-5","volume":"17","author":"M Curto","year":"2015","unstructured":"Curto M, Lionetto L, Negro A, Capi M, Fazio F, Giamberardino MA, Simmaco M, Nicoletti F, Martelletti P (2015) Altered kynurenine pathway metabolites in serum of chronic migraine patients. J Headache Pain 17:47. https:\/\/doi.org\/10.1186\/s10194-016-0638-5","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR107","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-016-0620-2","volume":"17","author":"M Curto","year":"2015","unstructured":"Curto M, Lionetto L, Negro A, Capi M, Perugino F, Fazio F, Giamberardino MA, Simmaco M, Nicoletti F, Martelletti P (2015) Altered serum levels of kynurenine metabolites in patients affected by cluster headache. J Headache Pain 17(1):27. https:\/\/doi.org\/10.1186\/s10194-016-0620-2","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR108","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10194-021-01239-1","volume":"22","author":"B Tuka","year":"2021","unstructured":"Tuka B, Ny\u00e1ri A, Cseh EK, K\u00f6rt\u00e9si T, Ver\u00e9b D, T\u00f6m\u00f6si F, Kecskem\u00e9ti G, Jan\u00e1ky T, Tajti J, V\u00e9csei L (2021) Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period. J Headache Pain 22(1):60. https:\/\/doi.org\/10.1186\/s10194-021-01239-1","journal-title":"J Headache Pain"},{"issue":"1","key":"1833_CR109","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-023-01570-9","volume":"24","author":"B Tuka","year":"2023","unstructured":"Tuka B, K\u00f6rt\u00e9si T, N\u00e1n\u00e1si N, T\u00f6m\u00f6si F, Jan\u00e1ky T, Ver\u00e9b D, Szok D, Tajti J, V\u00e9csei L (2023) Cluster headache and kynurenines. J Headache Pain 24(1):35. https:\/\/doi.org\/10.1186\/s10194-023-01570-9","journal-title":"J Headache Pain"},{"issue":"2","key":"1833_CR110","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","volume":"48","author":"I Jansen-Olesen","year":"2014","unstructured":"Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J (2014) PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides 48(2):53\u201364 Epub 2014 Jan 25. PMID: 24508136","journal-title":"Neuropeptides"},{"key":"1833_CR111","doi-asserted-by":"publisher","unstructured":"Liu C, Zhang Y, Liu Q, Jiang L, Li M, Wang S, Long T, He W, Kong X, Qin G, Chen L, Zhang Y, Zhou J P2X4-receptor participates in EAAT3 regulation via BDNF-TrkB signaling in a model of trigeminal allodynia. Mol Pain 2018 Jan-Dec 14:1744806918795930. https:\/\/doi.org\/10.1177\/1744806918795930. PMID: 30146940; PMCID: PMC6111400.","DOI":"10.1177\/1744806918795930"},{"issue":"10","key":"1833_CR112","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ejpain.2011.04.005","volume":"15","author":"P Anand","year":"2011","unstructured":"Anand P, Shenoy R, Palmer JE, Baines AJ, Lai RY, Robertson J, Bird N, Ostenfeld T, Chizh BA (2011) Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. Eur J Pain 15(10):1040\u20131048. https:\/\/doi.org\/10.1016\/j.ejpain.2011.04.005. Epub 2011 May 14. PMID: 21576029","journal-title":"Eur J Pain"},{"issue":"1","key":"1833_CR113","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12974-018-1285-3","volume":"15","author":"T Long","year":"2018","unstructured":"Long T, He W, Pan Q, Zhang S, Zhang Y, Liu C, Liu Q, Qin G, Chen L, Zhou J (2018) Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation. J Neuroinflammation 15(1):245. https:\/\/doi.org\/10.1186\/s12974-018-1285-3. PMID: 30165876; PMCID: PMC6117935","journal-title":"J Neuroinflammation"},{"key":"1833_CR114","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fneur.2017.00745","volume":"8","author":"T K\u00f6rt\u00e9si","year":"2018","unstructured":"K\u00f6rt\u00e9si T, Tuka B, Tajti J, Bagoly T, F\u00fcl\u00f6p F, Helyes Z, V\u00e9csei L (2018) Kynurenic acid inhibits the Electrical Stimulation Induced elevated pituitary adenylate cyclase-activating polypeptide expression in the TNC. Front Neurol 8:745. https:\/\/doi.org\/10.3389\/fneur.2017.00745. PMID: 29387039; PMCID: PMC5775965","journal-title":"Front Neurol"},{"issue":"8","key":"1833_CR115","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. FEBS J 279(8):1356\u20131365. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08485.x","journal-title":"FEBS J"},{"key":"1833_CR116","doi-asserted-by":"publisher","first-page":"108055","DOI":"10.1016\/j.pharmthera.2021.108055","volume":"236","author":"AS Pires","year":"2022","unstructured":"Pires AS, Sundaram G, Heng B, Krishnamurthy S, Brew BJ, Guillemin GJ (2022) Recent advances in clinical trials targeting the kynurenine pathway. Pharmacol Ther 236:108055. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108055","journal-title":"Pharmacol Ther"},{"issue":"23","key":"1833_CR117","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.3390\/cells11233795","volume":"11","author":"T K\u00f6rt\u00e9si","year":"2022","unstructured":"K\u00f6rt\u00e9si T, Spekker E, V\u00e9csei L (2022) Exploring the Tryptophan Metabolic pathways in Migraine-related mechanisms. Cells 11(23):3795. https:\/\/doi.org\/10.3390\/cells11233795. PMID: 36497053; PMCID: PMC9736455","journal-title":"Cells"},{"issue":"1","key":"1833_CR118","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12(1):64\u201382. https:\/\/doi.org\/10.1038\/nrd3793. Epub 2012 Dec 14. PMID: 23237916","journal-title":"Nat Rev Drug Discov"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01833-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:02:43Z","timestamp":1722970963000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01833-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01833-z","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors contributed to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}